-
at the MITH research group, with the anticipated PhD defence at the Faculty of Medicine, Vrije Universiteit Brussel. You will contribute to the development of GPRC5B-targeting nanobodies from initial discovery
-
per week at Amsterdam UMC. The academic embedding will be at the Amsterdam Leukodystrophy Center, with the anticipated PhD defence at the Faculty of Medicine, Vrije Universiteit Amsterdam. This PhD
-
cross-border access and reimbursement within the European Reference Network for Rare Neurological Diseases (ERN-RND) at University Hospital Tübingen. Your PhD will be awarded by the Faculty of Medicine
-
defence at the Faculty of Medicine, Vrije Universiteit Amsterdam. Would you like to know more about the different phases within the PhD trajectory? You can read more about this on this page . As a doctoral